RNAi-based Knockdown of Multidrug Resistance-associated Protein 1 is Sufficient to Reverse Multidrug Resistance of Human Lung Cells

Shao, Shu-Li; Cui, Ting-Ting; Zhao, Wei; Zhang, Wei-Wei; Xie, Zhen-Li; Wang, Chang-He; Jia, Hong-Shuang; Liu, Qian

추천

검색

자료유형: 학술저널

저자정보: Shao, Shu-Li (College of Life Sciences and Agriculture and Forestry, Qiqihar University) Cui, Ting-Ting (College of Life Sciences and Agriculture and Forestry, Qiqihar University) Zhao, Wei (Beijing systerm for Diseases Control and Prevention) Zhang, Wei-Wei (College of Life Sciences and Agriculture and Forestry, Qiqihar University) Xie, Zhen-Li (College of Life Sciences and Agriculture and Forestry, Qiqihar University) Wang, Chang-He (College of Life Sciences and Agriculture and Forestry, Qiqihar University) Jia, Hong-Shuang (College of Life Sciences and Agriculture and Forestry, Qiqihar University) Liu, Qian (College of Life Sciences and Agriculture and Forestry, Qiqihar University)

저널정보: 아시아태평양암예방학회 Asian Pacific journal of cancer prevention : APJCP Asian Pacific journal of cancer prevention : APJCP 제15권 제24호

발행연도: 2014.1

수록면: 10,597 - 10,601 (5page)

이용수

📌

연구주제

📖

연구배경

🔬

연구방법

🏆

연구결과

초록· 키워드

오류제보하기

Up-regulation of multidrug resistance-associated protein 1 (MRP1) is regarded as one of the main causes for multidrug resistance (MDR) of tumor cells, leading to failure of chemotherapy-based treatment for a multitude of cancers. However, whether silencing the overexpressed MRP1 is sufficient to reverse MDR has yet to be validated. This study demonstrated that RNAi-based knockdown of MRP1 reversed the increased efflux ability and MDR efficiently. Two different short haipin RNAs (shRNAs) targeting MRP1 were designed and inserted into pSilence-2.1-neo. The shRNA recombinant plasmids were transfected into cis-dichlorodiamineplatinum-resistant A549 lung (A549/DDP) cells, and then shRNA expressing cell clones were collected and maintained. Real time PCR and immunofluorescence staining for MRP1 revealed a high silent efficiency of these two shRNAs. Functionally, shRNA-expressing cells showed increased rhodamine 123 retention in A549/DDP cells, indicating reduced efflux ability of tumor cells in the absence of MRP1. Consistently, MRP1-silent cells exhibited decreased resistance to 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) and DDP, suggesting reversal of MDR in these tumor cells. Specifically, MRP1 knockdown increased the DDP-induced apoptosis of A549/DDP cells by increased trapping of their cell cycling in the G2 stage. Taken together, this study demonstrated that RNAi-based silencing of MRP1 is sufficient to reverse MDR in tumor cells, shedding light on possible novel clinical treatment of cancers.

#Multidrug resistance #MRP1 #ShRNA #protein expression #tumor cells

참고문헌 (0)

참고문헌 신청

참고문헌이 DBpia에서 서비스 중이라면, [참고문헌 신청]을 통해 등록해보세요